Results 71 to 80 of about 45,467 (263)

Thoracic duct identification with indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position

Diseases of the esophagus, 2020
Chylothorax is a serious complication of transthoracic esophagectomy. Intraoperative thoracic duct (TD) identification represents a possible tool for preventing or repairing its lesions, and it is most of the time difficult, even during high-definition ...
M. Vecchiato, A. Martino, M. Sponza, A. Uzzau, Antonio Ziccarelli, F. Marchesi, R. Petri   +6 more
semanticscholar   +1 more source

Influence of Facility Size on Perioperative Outcomes in Minimally Invasive Esophagectomy for 14 152 Patients With Esophageal Cancer Based on the Japanese National Clinical Database: A Multicenter Cohort Study

Annals of Gastroenterological Surgery, EarlyView.
This multicenter study investigated 14 152 minimally invasive esophagectomies (MIEs) using data from the Japanese National Clinical Database and showed a significantly lower operative mortality rate in high‐volume centers than in low‐volume centers. However, no differences in morbidity rates were found between facility sizes.
Taro Oshikiri, Hisateru Tachimori, Hiroaki Miyata, Yoshihiro Kakeji, Ken Shirabe   +4 more
wiley   +1 more source

Short- and mid-term outcomes of robotic versus thoraco-laparoscopic McKeown esophagectomy for squamous cell esophageal cancer: a propensity score-matched study.

Diseases of the esophagus, 2020
Controversy exists on the advantages of robotic McKeown esophagectomy (RME) versus thoraco-laparoscopic McKeown esophagectomy (TLME). The aim was to evaluate the short- and mid-term outcomes of RME and TLME in the treatment of patients with esophageal ...
Yu Yang, Xinxin Zhang, Benshang Li, Rong Hua, Yi He, B. Ye, Xiaokui Guo, Yun Sun, Zonghai Li   +8 more
semanticscholar   +1 more source

Perioperative Clinical Results of Transcervical and Transhiatal Esophagectomy versus Thoracoscopic Esophagectomy in Patients with Esophageal Carcinoma: A Prospective, Randomized, Controlled Study

International Journal of General Medicine, 2022
Zhe Yin,1,* Ren-Mei Yang,1,* Yue-Quan Jiang,1 Qi Chen,2 Hua-Rong Cai1 1Department of Thoracic Surgery, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing, 400030, People’s Republic of China; 2Department of Anesthesiology ...
Yin Z, Yang RM, Jiang YQ, Chen Q, Cai HR
doaj  

Management of Clinical T1N0M0 Esophageal Cancer

Gut and Liver, 2019
Background/Aims Endoscopic resection is a standard treatment for stage T1a esophageal cancer, with esophagectomy or radical radiation therapy (RT) performed for stage T1b lesions.
Andrew J. Yang, Seo Hee Choi, Hwa Kyung Byun, Hyun Ju Kim, Jinhyun Choi, Yong Chan Lee, Sang Kil Lee, Kyung Ran Park, Chang Geol Lee   +8 more
doaj   +1 more source

Survival Outcomes of Esophageal Squamous Cell Carcinoma Patients Who Underwent Salvage Esophagectomy: A Literature Review and Results From Two High‐Volume Centers

Annals of Gastroenterological Surgery, EarlyView.
This study aimed to investigate survival outcomes, the efficacy of lymph node (LN) dissection, and recurrence patterns in 69 patients who underwent R0 salvage surgery for esophageal squamous cell carcinoma. Of note, abdominal LN metastases had a negative impact on survival in our series.
Kotaro Sugawara, Koichi Yagi, Takashi Fukuda, Shoh Yajima, Daiji Oka, Yoshiyuki Miwa, Shuichiro Oya, Asami Okamoto, Raito Asaoka, Yoshifumi Baba   +9 more
wiley   +1 more source

Esophagectomy for benign disease [PDF]

Journal of Thoracic Disease, 2018
Esophagectomy for benign disease is uncommonly used but it is an important option to consider in those patients who have lost function of this organ. Esophageal resection is, in fact considered as a last resort for benign disease, after multiple failed conservative treatments, when the primary disease is not amenable to other treatments and the ...
Jessica Mormando, Daniela Molena, Arianna Barbetta   +2 more
openaire   +2 more sources

A STUDY AND EVALUATION OF MAKEOWN'S ESOPHAGECTOMY OUTCOMES WITH COST AND BENEFIT ANALYSIS: A SINGLE INSTITUTIONAL REVIEW

National Journal of Medical Research, 2019
Background: A minimally invasive approach to esophagectomy is being used increasingly, but concerns remain regarding the feasibility, safety, cost, and outcomes.
Dhruv Patel, Vinodkumar Dhakad, Elroy Saldanha, Nikhil Mehta, Sanjay Desai   +4 more
doaj  

Surgical Treatment of Siewert II Gastroesophagel Junction Adenocarcinoma: Esophagectomy or Gastrectomy? Review

Lietuvos Chirurgija, 2022
Introduction. Surgery is the only curative treatment option for patients with gastroesophageal junction (GEJ) adenocarcinoma. These tumors can be resected by gastrectomy or esophagectomy depending on tumor localization.
Ugnė Imbrasaitė, Dovilė Giršvildaitė, Rimantas Baušys, Augustinas Baušys   +3 more
doaj   +1 more source

Long‐Term Survival of Two Versus Three Courses of Preoperative Cisplatin and Fluorouracil Plus Docetaxel for Locally Advanced Esophageal Cancer: A Multicenter Randomized Phase II Trial

Annals of Gastroenterological Surgery, EarlyView.
This multi‐institutional, randomized, phase II trial aimed to investigate the long‐term survival outcomes of two versus three courses of DCF for locally advanced esophageal squamous cell carcinoma (ESCC). The 5‐year overall survival and progression‐free survival rates for the three and two course groups were 70.7% vs. 63.8% (hazard ratio (HR) = 0.91, p 
Takahito Sugase, Hiroshi Miyata, Takashi Kanemura, Norihiro Matsuura, Tomoki Makino, Makoto Yamasaki, Koji Tanaka, Kotaro Yamashita, Kota Momose, Osamu Shiraishi, Keijiro Sugimura, Masaaki Motoori, Kazumasa Fujitani, Atsushi Takeno, Motohiro Hirao, Yutaka Kimura, Taroh Satoh, Masahiko Yano, Yuichiro Doki, Takushi Yasuda   +19 more
wiley   +1 more source